General Information of the Compound
| Compound ID |
CP0393323
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-amino-7-morpholin-4-yl-5-oxo-N-(2H-tetrazol-5-yl)chromeno[2,3-b]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H16N8O4
|
||||||||||||||||||
| Molecular Weight |
408.378
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc2oc3ccc(cc3c(=O)c2cc1C(=O)Nc1nn[nH]n1)N1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H16N8O4/c19-15-12(16(28)21-18-22-24-25-23-18)8-11-14(27)10-7-9(26-3-5-29-6-4-26)1-2-13(10)30-17(11)20-15/h1-2,7-8H,3-6H2,(H2,19,20)(H2,21,22,23,24,25,28)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AJNUNEZPUCBMIF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01072, Inhibitor of nuclear factor kappa-B kinase subunit epsilon
Protein ID: PT01682, Serine/threonine-protein kinase TBK1